The benefit of Beam's eye view based 3D treatment planning for cervical cancer

被引:39
作者
Gerstner, N
Wachter, S
Knocke, TH
Fellner, C
Wambersie, A
Pötter, R
机构
[1] Univ Hosp Vienna, Dept Radiotherapy & Radiobiol, A-1090 Vienna, Austria
[2] Clin Univ St Luc, B-1200 Brussels, Belgium
关键词
cervical cancer; three-dimensional treatment planning; dose-volume-histograms; Beam's eye view;
D O I
10.1016/S0167-8140(99)00038-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to evaluate the possibility of Beam's eye view (BEV) based three dimensional (3D) treatment planning, to reduce portions of organs at risk included in the treated volume without increasing the risk of geographical miss in external beam therapy of cervical cancer. Materials and methods: Three dimensional dose distribution of BEV based 3D treatment plans was compared to the 3D dose distribution derived from a four-field-box-technique using standard portals. A total of 20 patients with cervical cancer stage FIGO IIB and FIGO IIIB was included. Dose distribution in the target volumes and in the organs at risk of BEV based treatment planning, was compared to the dose distribution of the standard field technique using dose-volume-histograms. Results: In 4/20 patients (20%) a geographical miss at the cervix uteri was observed for the standard field technique. The BEV based treatment planning resulted in an adequate coverage of target volume and additionally in a reduction of portions of bladder and bowel Volume included in the treated volume (-13.5, -10%). In contrast the BEV based technique resulted in an increase of portions of the rectum volume included in the treated volume compared to standard portals due to a shift of the rectum by the enlarged cervix uteri from its posterior to a lateral position. An overall 7% reduction of treated volume was observed, although the maximum width of lateral fields increased for the BEV technique. Moreover, we have found a remarkable impact of bladder fillings on the amount of bowel and bladder volume included in the treated volume. Conclusion: BEV based 3D treatment planning for external beam therapy of cervical cancer offers a possibility to avoid geographical miss of part of the CTV with reduced portions of bladder and bowel volume included in the treated volume. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 25 条
[1]  
[Anonymous], 1993, 50 ICRU
[2]  
[Anonymous], 1985, 38 ICRU
[3]   MULTIDIMENSIONAL TREATMENT PLANNING .2. BEAM EYE-VIEW, BACK PROJECTION, AND PROJECTION THROUGH CT SECTIONS [J].
GOITEIN, M ;
ABRAMS, M ;
ROWELL, D ;
POLLARI, H ;
WILES, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (06) :789-797
[4]   GYNECOLOGIC RADIOTHERAPY FIELDS DEFINED BY INTRAOPERATIVE MEASUREMENTS [J].
GREER, BE ;
KOH, WJ ;
FIGGE, DC ;
RUSSELL, AH ;
CAIN, JM ;
TAMIMI, HK .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :421-424
[5]   Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >=10 ng/ml [J].
Hanks, GE ;
Lee, WR ;
Hanlon, AL ;
Hunt, M ;
Kaplan, E ;
Epstein, BE ;
Movsas, B ;
Schultheiss, TE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (05) :861-868
[6]   FACTORS INFLUENCING INCIDENCE OF ACUTE GRADE-2 MORBIDITY IN CONFORMAL AND STANDARD RADIATION TREATMENT OF PROSTATE-CANCER [J].
HANKS, GE ;
SCHULTHEISS, TE ;
HUNT, MA ;
EPSTEIN, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (01) :25-29
[7]  
*ICRU, 1998, 50 ICRU S
[8]   Magnetic resonance imaging (MRI): Considerations and applications in radiotherapy treatment planning [J].
Khoo, VS ;
Dearnaley, DP ;
Finnigan, DJ ;
Padhani, A ;
Tanner, SF ;
Leach, MO .
RADIOTHERAPY AND ONCOLOGY, 1997, 42 (01) :1-15
[9]   CONVENTIONAL 4-FIELD PELVIC RADIOTHERAPY TECHNIQUE WITHOUT CT TREATMENT PLANNING IN CANCER OF THE CERVIX - POTENTIAL GEOGRAPHIC MISS [J].
KIM, RY ;
MCGINNIS, LS ;
SPENCER, SA ;
MEREDITH, RF ;
JENNELLE, RLS ;
SALTER, MM .
RADIOTHERAPY AND ONCOLOGY, 1994, 30 (02) :140-145
[10]  
KNOCKE HT, 1998, IN PRESS STRAHLENTHE